Let innovative achievements better benefit people's health! Chen Jining Meets with Wan Sihan, CEO of Novartis AG in Switzerland
Chen Jining, Secretary of the Municipal Party Committee, met this morning with the delegation led by Wan Sihan, CEO of Novartis AG in Switzerland.
Chen Jining said that the 20th National Congress of the Communist Party of China has mapped out a grand blueprint for Chinese path to modernization. To enable the people to live a better life, provide better health and medical services, and continuously improve the health and well-being of the people, is an important focus of promoting high-quality development. Biopharmaceuticals is one of the three leading industries vigorously developed in Shanghai, and Novartis Group is a global leading pharmaceutical company. The development concepts of both parties are in line and the cooperation space is broad. Welcome Novartis Group to further increase its investment in research, development, and production layout in Shanghai, fully combining its own innovation and technological advantages with Shanghai's research and development advantages, clinical advantages, and policy advantages, accelerating the transformation into industrial advantages, and making innovation achievements better benefit people's health. We will carefully listen to the needs and suggestions of enterprises, vigorously create a market-oriented, legal, and international first-class business environment, optimize institutional supply, provide convenient services, and help enterprises achieve better and greater development in Shanghai.
Wan Sihan introduced Novartis Group's global business and development in China. He stated that Novartis is accelerating its transformation towards the strategic positioning of a high-tech innovative pharmaceutical company. The Chinese market is one of Novartis's most important global markets, and thanks to the favorable business environment and open policy support in China and Shanghai, it has achieved fruitful results in its development in China. We will firmly cultivate the Chinese market, continue to increase investment, and carry out practical cooperation in various fields such as clinical research, research and development production, so as to better serve patients and enhance health and well-being with new technologies, therapies, and products.
City leaders Zhu Zhisong and Li Zheng attended the meeting.